Rhabdomyosarcomatous Transformation of a Gastrointestinal Stromal Tumor following Treatment with Imatinib.

about

Rhabdomyosarcomatous Transformation of a Gastrointestinal Stromal Tumor following Treatment with Imatinib.

Item

http://www.wikidata.org/entity/Q38361061

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Rhabdomyosarcomatous Transform ...... owing Treatment with Imatinib.

@en

type

Item

label

Rhabdomyosarcomatous Transform ...... owing Treatment with Imatinib.

@en

prefLabel

Rhabdomyosarcomatous Transform ...... owing Treatment with Imatinib.

@en

P1476

Rhabdomyosarcomatous Transform ...... lowing Treatment with Imatinib

@en

P2093

Cynthia D Guy

http://www.w3.org/2001/XMLSchema#string

Diana M Cardona

http://www.w3.org/2001/XMLSchema#string

H Bryan Anderson

http://www.w3.org/2001/XMLSchema#string

Paul J Mosca

http://www.w3.org/2001/XMLSchema#string

Richard F Riedel

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Biology of gastrointestinal stromal tumors.

Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.

The GIST paradigm: lessons for other kinase-driven cancers.

Gastrointestinal stromal tumors: morphological, immunohistochemical and molecular changes associated with kinase inhibitor therapy.

Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.

Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variant.

P304

317493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/317493

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Xiaoyin Jiang

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272516554

http://www.w3.org/2001/XMLSchema#string

P698

25694839

http://www.w3.org/2001/XMLSchema#string

P932

4324915

http://www.w3.org/2001/XMLSchema#string